İsmail Şimşek

Lorecivivint, a Novel Intraarticular CDC‐like Kinase 2 and Dual‐Specificity Tyrosine Phosphorylation‐Regulated Kinase 1A Inhibitor and Wnt Pathway Modulator for the Treatment of Knee Osteoarthritis: A Phase II Randomized Trial

Timothy E. McAlindon, Allan Gibofsky, Nancy E. Lane et al. · Arthritis & Rheumatology · 2020 · 142 citations · Full text

Medicine, Orthopedic Surgery, Pharmacology +17

A Phase 2b randomized trial of lorecivivint, a novel intra-articular CLK2/DYRK1A inhibitor and Wnt pathway modulator for knee osteoarthritis

T.E. McAlindon, Allan Gibofsky, Nancy E. Lane et al. · Osteoarthritis and Cartilage · 2021 · 107 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Serum proinflammatory cytokines directing T helper 1 polarization in patients with familial Mediterranean fever

İsmail Şimşek, Salih Pay, Aysel Pekel et al. · Rheumatology International · 2007 · 46 citations

Life Sciences, Immunology, Pathology +16

Penetration of Meropenem and Cefepim into Pancreatic Tissue During the Course of Experimental Acute Pancreatitis

U. Saǧlamkaya, Mehmet Refik Mas, Mehmet Yaşar et al. · Pancreas · 2002 · 30 citations

Medicine, Pharmacokinetics, Pharmacology +13

Randomized Trial of Pimecrolimus Cream plus Colchicine Tablets versus Colchicine Tablets in the Treatment of Genital Ulcers in Behçet’s Disease

Osman Köse, Ayhan Dinç, İsmail Şimşek · Dermatology · 2008 · 29 citations

Medicine, Dermatology, Pharmacotherapy +13